Adenosquamous carcinoma of the uterine cervix - adjuvant chemotherapeutic treatment with paclitaxel and carboplatin; a case report

被引:0
作者
Radic, V [1 ]
Kukura, V [1 ]
Ciglar, S [1 ]
机构
[1] Univ Zagreb, Merkur Univ Hosp, Zagreb, Croatia
关键词
cervical adenosquamous cancer; adjuvant chemotherapy; paclitaxel; carboplatin;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Adenosquamous carcinoma of the uterine cervix is a rare mixture of malignant glandular and squamous epithelial elements. We present a case of a 56-year-old woman with Stage IV cervical carcinoma treated with paclitaxel and carboplatin chemotherapy after cytoreductive surgery. Solitary liver metastases were treated by ultrasound guided percutaneous sclerotherapy with 95% ethanol. For ten months the patient showed an objective response to the treatment with a good quality of life during that time. A year after the first, the second cytoreductive operation was performed and chemotherapy (paclitaxel, carboplatin, and epirubicin) followed. The patient died 20 months after establishing the diagnosis. Paclitaxel in combination with carboplatin as adjuvant chemotherapeutic treatment could be another promising agent for patients with advanced metastatic cervical adenocarcinoma.
引用
收藏
页码:449 / 450
页数:2
相关论文
共 14 条
[1]   Treatment of recurrent cervical adenocarcinoma with BMS-247550, an epothilone B analog [J].
Agrawal, M ;
Edgerly, M ;
Fojo, T ;
Kotz, H .
GYNECOLOGIC ONCOLOGY, 2003, 90 (01) :96-99
[2]   Paclitaxel, an active agent in nonsquamous carcinomas of the uterine cervix: A Gynecologic Oncology Group Study [J].
Curtin, JP ;
Blessing, JA ;
Webster, KD ;
Rose, PG ;
Mayer, AR ;
Fowler, WC ;
Malfetano, JH ;
Alvarez, RD .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) :1275-1278
[3]  
Kudelka AP, 1996, CLIN CANCER RES, V2, P1285
[4]   Paclitaxel has moderate activity in squamous cervix cancer: A gynecologic oncology group study [J].
McGuire, WP ;
Blessing, JA ;
Moore, D ;
Lentz, SS ;
Photopulos, G .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :792-795
[5]   Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: A gynecologic oncology group study [J].
Moore, DH ;
Blessing, JA ;
McQuellon, RP ;
Thaler, HT ;
Cella, D ;
Benda, J ;
Miller, DS ;
Olt, G ;
King, S ;
Boggess, JF ;
Rocereto, TF .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) :3113-3119
[6]  
Napolitano C, 2003, EUR J GYNAECOL ONCOL, V24, P51
[7]   Remission of metastatic cervical adenocarcinoma with weekly paclitaxel [J].
Ota, S ;
Sugiyama, T ;
Ushijima, K ;
Fujiyoshi, K ;
Komai, K ;
Hirai, N ;
Nishida, T ;
Kamura, T .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2001, 11 (02) :167-168
[8]   Phase II trial of neoadjuvant paclitaxel and cisplatin in uterine cervical cancer [J].
Park, DC ;
Kim, JH ;
Lew, YO ;
Kim, DH ;
Namkoong, SE .
GYNECOLOGIC ONCOLOGY, 2004, 92 (01) :59-63
[9]  
PERU E, 2003, EUR J GYNECOL ONCOL, V24, P473
[10]   Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri [J].
Pignata, S ;
Frezza, P ;
Tramontana, S ;
Perrone, F ;
Tambaro, R ;
Casella, G ;
Ferrari, E ;
Iodice, F ;
De Vivo, R ;
Ricchi, P ;
Tramontana, F ;
Silvestro, G .
ANNALS OF ONCOLOGY, 2000, 11 (04) :455-459